Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 4.910
+0.010 (0.20%)
Aug 21, 2026, 3:59 PM GMT
[Name] Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 49.7 | 49.7 | 32.18 | 13.09 | 5.5 | 2.06 |
Revenue Growth | 19.78% | 54.45% | 145.93% | 137.95% | 167.36% | -85.50% |
Gross Profit Gross Profit Growth | 23.04 | 23.04 | 14.93 | 4.03 | 2.46 | 0.73 |
Operating Income Operating Income Growth | -10.05 | -10.05 | -22.87 | -31.33 | -31.65 | -27.48 |
Net Income Net Income Growth | -17.66 | -17.66 | -27.18 | -33.29 | -49.79 | -26.65 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.03 | -0.05 | -0.21 | -0.13 |
EPS Growth | - | - | - | - | - | - |
Revenue by Geography
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
The Netherlands The Netherlands Growth | 2.76 | 2.76 | 2.14 | 1.5 | 1.78 | 1.23 |
Canada Canada Growth | 0.83 | 0.83 | 0.32 | - | 0.19 | - |
South Korea South Korea Growth | - | - | 0.12 | 0.02 | 0.01 | 0.74 |
Japan Japan Growth | 0.34 | 0.34 | 0.32 | - | - | - |
United States United States Growth | 45.78 | 45.78 | 29.27 | 11.57 | 3.53 | 0.08 |
Total Total Growth | 49.7 | 49.7 | 32.18 | 13.09 | 5.49 | 2.06 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11.62 | 11.62 | 6.52 | 13.95 | 3.4 | 16.41 |
Total Debt Total Debt Growth | 30.14 | 30.14 | 26.37 | 20.25 | 6.79 | 0.21 |
Net Cash (Debt) Net Cash Growth | -18.51 | -18.51 | -19.85 | -6.3 | -3.39 | 16.2 |
Net Cash Growth | - | - | - | - | - | 307.37% |
Net Cash Per Share Net Cash Per Share Growth | -0.02 | -0.02 | -0.03 | -0.01 | -0.01 | 0.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.38 | -3.38 | -6.77 | -37.13 | -22.59 | -24.73 |
Capital Expenditures CapEx Growth | -0.02 | -0.02 | -0.04 | -0.24 | -0.06 | -0.5 |
Free Cash Flow Free Cash Flow Growth | -3.4 | -3.4 | -6.81 | -37.37 | -22.66 | -25.23 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.36% | 46.36% | 46.39% | 30.78% | 44.70% | 35.48% |
Operating Margin | -20.22% | -20.22% | -71.08% | -239.44% | -575.49% | -1336.01% |
Pretax Margin | -34.49% | -34.49% | -82.52% | -247.42% | -897.31% | -1310.53% |
Profit Margin | -35.52% | -35.52% | -84.47% | -254.44% | -905.42% | -1295.46% |
FCF Margin | -6.85% | -6.85% | -21.15% | -285.56% | -411.98% | -1226.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 113.42 | 113.42 | 113.42 | 113.42 | 113.42 |
PS Ratio | 1.17 | 2.83 | 0.82 | 5.10 | 4.01 | 63.24 |